Research and Development
Pipeline
The Company currently has a number of therapeutic agents in clinical development that will generate solutions for chronic disease states by developing Medical Food therapies designed to deliver innovative treatment options for a wide range of diseases associated with increased nutritional requirements. The Company is currently developing products that will address the increased nutrient requirements associated with osteoporosis, macular degeneration, growth hormone deficiency, renal failure, and asthma. The Company's goal is to provide the correct therapeutic option, at the optimal time, at the appropriate dose, with the least side effects for the health and safety of patients.
Targeted Medical Pharma Inc. is shifting the paradigm of therapeutic applications from the single molecule model to a multi-molecule, nutrient based model one product at a time.
